Bank of Montreal
SRNE

Bank of Montreal’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bank of Montreal’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,700
Closed -$45.7K – 4453
2022
Q4 		$45.7K Hold
27,700
– – ﹤0.01% 3559
2022
Q3 		$58 Hold
27,700
– – ﹤0.01% 3602
2022
Q2 		$58 Hold
27,700
– – ﹤0.01% 3597
2022
Q1 		$70K Buy
+27,700
New +$86.4K ﹤0.01% 3734
2021
Q2 		– Sell
-58,300
Closed -$451K – 5288
2021
Q1 		$451K Sell
58,300
-41,400
-42% -$437K ﹤0.01% 2703
2020
Q4 		$716K Buy
99,700
+99,200
+19,840% +$797K ﹤0.01% 2490
2020
Q3 		$5K Buy
+500
New +$4.58K ﹤0.01% 4464
2019
Q3 		– Sell
-400
Closed -$1K – 5073
2019
Q2 		$1K Hold
400
– – ﹤0.01% 4815
2019
Q1 		$2K Sell
400
-5,100
-93% -$13.4K ﹤0.01% 4176
2018
Q4 		$13K Sell
5,500
-141,000
-96% -$460K ﹤0.01% 3816
2018
Q3 		$645K Buy
146,500
+90,300
+161% +$501K ﹤0.01% 2212
2018
Q2 		$405K Buy
+56,200
New +$382K ﹤0.01% 2427

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Bank of Montreal's SRNE Position: Q1 2023 in Review

Bank of Montreal sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 33,243 shares — an estimated $54.9K sold.

Bank of Montreal first reported a position in SRNE in Q2 2016 and held it in 23 quarters. The position peaked at $1.38M in Q1 2019. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Bank of Montreal reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 33,243 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $54.9K.
  • Bank of Montreal first reported a position in Sorrento Therapeutics, Inc. in Q2 2016 and held it in 23 quarters.
  • Bank of Montreal's Sorrento Therapeutics, Inc. position peaked at $1.38M in Q1 2019.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.